TMO

SEC source: 0001127602-20-022203 · form4.xml · derivative · entry 16

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,300

Underlying: Common Stock · 4,100 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The option vests in four equal annual installments. One-quarter of the shares vested on February 26, 2020, and the remaining three quarters will vest on February 26, 2021, 2022 and 2023.

SEC source: 0001127602-20-022203 · form4.xml · derivative · entry 15

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,150

Underlying: Common Stock · 4,575 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The option vests in four equal annual installments. One-quarter of the shares vested on February 27, 2019 and February 27, 2020, and the remaining two quarters will vest on February 27, 2021 and February 27, 2022.

SEC source: 0001127602-20-022203 · form4.xml · derivative · entry 14

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,200

Underlying: Common Stock · 6,200 shares

Expires 2024-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests in four equal annual installments. One-quarter of the shares vested on February 28, 2018, 2019 and 2020, and the remaining one-quarter will vest on February 28, 2021.

SEC source: 0001127602-20-022203 · form4.xml · derivative · entry 13

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,638 shares

Expires 2023-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 11

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,019

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.81 to $414.71, inclusive.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 10

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 9

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,019

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.06 to $415.29, inclusive.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 8

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,719

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.74 to $414.545, inclusive.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 7

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 6

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,019

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 5

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 4

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,019

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.86 to $416.17, inclusive.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 3

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,332

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.84 to $415.815, inclusive.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 2

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,557

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.785 to $414.66, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4.

SEC source: 0001127602-20-022203 · form4.xml · nonDerivative · entry 1

Jafry Syed A. · CIK 0001745891 · Sr. Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,657

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 6

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,986

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 5

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,704

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.19 to $405.27, inclusive.

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 4

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,004

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.20 to $404.00, inclusive.

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 3

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,904

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.62 to $401.80, inclusive.

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 2

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,063

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.20 to $400.68 inclusive.

SEC source: 0001127602-20-022166 · form4.xml · nonDerivative · entry 1

MANZI JIM P · CIK 0001216076 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,803

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.15 to $399.74, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4.

SEC source: 0001127602-20-022170 · form4.xml · derivative · entry 11

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2021-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The option vested in four equal installments on February 26, 2015, 2016, 2017, and 2018.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 8

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,621

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.995 to $406.90, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 7

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,252

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.98 to $405.97, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 6

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,221

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.97 to $404.90, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 5

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,258

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.97 to $403.96, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 4

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,621

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.96 to $402.95, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 3

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,921

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.84 to $401.12, inclusive.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 2

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,221

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.65 to $399.81, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.

SEC source: 0001127602-20-022170 · form4.xml · nonDerivative · entry 1

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-022172 · form4.xml · derivative · entry 7

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 20,000 shares

Expires 2022-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in four equal installments on February 25, 2016, 2017, 2018, and 2019.

SEC source: 0001127602-20-022172 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,445.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2020.

SEC source: 0001127602-20-022172 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,445.53

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-021165 · form4.xml · nonDerivative · entry 1

Boxer Michael A · CIK 0001726596 · Sr. VP and Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,471

SEC source: 0001127602-20-024321 · form4.xml · nonDerivative · entry 2

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Stevenson 2010 Living Trust

Disclosed balance after: 68,019

SEC source: 0001127602-20-024321 · form4.xml · nonDerivative · entry 1

Stevenson Mark · CIK 0001387890 · Executive Vice President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,561

F1 · kind: Gift of securities by the reporting person to a revocable living trust.

SEC source: 0000899243-20-017990 · doc4.xml · derivative · entry 1

SPERLING SCOTT M · CIK 0001214212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,850.93

Underlying: Common Stock · 66.78 shares

Expires not disclosed

F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis.

F2 · price: Represents stock units credited to the Reporting Person's account as of June 27, 2020, at a price of $350.95 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of June 27, 2020, at a price of $350.95 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of June 27, 2020, at a price of $350.95 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

SEC source: 0001127602-20-018847 · form4.xml · derivative · entry 7

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,795 shares

Expires 2021-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in four equal installments on February 26, 2015, 2016, 2017, and 2018.

SEC source: 0001127602-20-018847 · form4.xml · nonDerivative · entry 5

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Marc N. Casper 2020 Irrevocable Trust

Disclosed balance after: 34,500

F4 · kind: Gift of securities by the reporting person to an irrevocable trust for the benefit of his children.

SEC source: 0001127602-20-018847 · form4.xml · nonDerivative · entry 4

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,445.53

F4 · kind: Gift of securities by the reporting person to an irrevocable trust for the benefit of his children.

SEC source: 0001127602-20-018847 · form4.xml · nonDerivative · entry 3

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,945.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.235, inclusive.

SEC source: 0001127602-20-018847 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,762.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.00 to $349.99, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

SEC source: 0001127602-20-018847 · form4.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,740.53

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-018424 · form4.xml · derivative · entry 8

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,795

Underlying: Common Stock · 20,000 shares

Expires 2021-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in four equal installments on February 26, 2015, 2016, 2017 and 2018.

SEC source: 0001127602-20-018424 · form4.xml · nonDerivative · entry 5

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,945.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.01 to $350.88, inclusive.

SEC source: 0001127602-20-018424 · form4.xml · nonDerivative · entry 4

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,532.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.00 to $349.98, inclusive.

SEC source: 0001127602-20-018424 · form4.xml · nonDerivative · entry 3

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,945.53

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-018427 · form4.xml · nonDerivative · entry 1

Williamson Stephen · CIK 0001648929 · Sr. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,989

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2018.

SEC source: 0001127602-20-018424 · form4.xml · derivative · entry 7

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,795

Underlying: Common Stock · 20,000 shares

Expires 2021-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested in four equal installments on February 26, 2015, 2016, 2017 and 2018.

SEC source: 0001127602-20-018424 · form4.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,945.53

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.00 to $349.718, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.